Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM Plunges 5%; BSE HEALTHCARE Index Down 0.0%
Tue, 13 Aug 9:22

NGL FINE CHM Plunges 5%; BSE HEALTHCARE Index Down 0.0%Image source: peterschreiber.media/www.istockphoto.com

NGL FINE CHM share price has plunged 5% and is presently trading at Rs 2,500.0.

Meanwhile, the BSE HEALTHCARE index is at 41,035.2 .

Among the top losers in the BSE HEALTHCARE index today are Cadila Healthcare (down 1.9%) and Divis Laboratories (down 1.6%).

ASTRAZENECA PHARMA (up 4.4%) and Natco Pharma (up 2.3%) are among the top gainers today.

Over the last one year, NGL FINE CHM has moved up from Rs 2,140.9 to Rs 2,500.0, registering a gain of Rs 359.1 (up 16.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,035.2, registering a gain of 44.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 111.7%), Jubilant Pharmova (up 110.7%) and SUVEN PHARMACEUTICALS (up 108.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,622.2 .

The top losers among the BSE Sensex today are HDFC Bank (down 2.3%) and Asian Paints (down 0.6%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,330.5 (down 0.1%). HDFC Bank and Divis Laboratories are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,622.2, registering a gain of 13,626.4 points (up 20.6%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 32.2% YoY to Rs 123 million for the quarter ended March 2024, compared to a profit of Rs 93 million a year ago. Net sales rose 35.0% to Rs 998 million during the period as against Rs 739 million in January-March 2023.

For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 37.4.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 5%; BSE HEALTHCARE Index Down 0.0%". Click here!